Chief Executive Officer
Patrik Dahlen holds a MSc in Biochemistry from Åbo Akademi University and a PhD in Biochemistry from Turku University. He brings over 30 years of senior level experience as an executive in the life science and diagnostics industry. Patrik contributes with broad international experience in Europe and the US with substantial diagnostic and international industry expertise. As Chief Executive Officer of Dako, Patrik, carried out a major strategic repositioning of the company as a leading supplier of cancer diagnostics. As President of Life Sciences at the American company Perkin Elmer, Patrik was instrumental in building the company’s diagnostic business with a niche focus on diagnostic systems for neonatal and prenatal screening. He has led organizations ranging from 10 to 2000 people based in Finland, Denmark, UK and USA and has considerable public company experience. Additional experience includes CEO, SSI Diagnostic, Denmark, CEO, Immunodiagnostic Systems (IDS), UK; CEO NeuroSearch, Denmark.
Current assignments: Chairman of the Board of Visiopharm and Advalight. Board member of SSI Diagnostica.
Previous assignments (last five years): Board Member of LEO Pharma and Immunovia AB.